The Novel Coronavirus 2019 epidemic and kidneys
Top Cited Papers
- 8 March 2020
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 97 (5), 824-828
- https://doi.org/10.1016/j.kint.2020.03.001
Abstract
No abstract availableKeywords
Funding Information
- Baxter Healthcare Corporation
- GlaxoSmithKline Australia
This publication has 19 references indexed in Scilit:
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus InfectionAnnals of Internal Medicine, 2014
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- Serum IL‐6 and IL‐1‐ra with sequential organ failure assessment scores in septic patients receiving high‐volume haemofiltration and continuous venovenous haemofiltrationNephrology, 2006
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Treatment of Severe Acute Respiratory Syndrome With GlucosteroidsChest, 2006
- Acute renal impairment in coronavirus-associated severe acute respiratory syndromeKidney International, 2005
- Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathwaysThe Journal of Pathology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003